With one month to go, fund managers should be ramping up their preparations for complying with the legislative changes to European Union (“EU”) Alternative Investment Fund Managers Directive (“AIFMD”), commonly referred to as “AIFMD 2.0”, which will come into effect in EU member countries on 16 April 2026.

The majority of the changes will apply to EU authorised alternative investment fund managers (“EU AIFMs”), but there are elements of AIFMD 2.0 that will also apply to non‑EU AIFMs that market their funds in the EU under the National Private Placement Regimes (“NPPRs”).

For fund managers that have only fundraised in the EU in reliance of reverse solicitation there will be no changes arising under AIFMD 2.0.  Furthermore, the UK is not implementing under AIFMD 2.0 so there will no change for fund managers that have marketed in the UK under UK NPPR.

Preparation

Fund sponsors that are currently within the scope of AIFMD should be assessing the changes that may need to be made to comply with the new requirements.  If a fund sponsor has engaged a third party EU AIFM to manage one or more of its funds then it should check with its third-party AIFM if any changes need to be made to the current fund arrangements, policies and agreements. 

Some of the key changes arising under the AIFMD 2.0 that are relevant for EU AIFMs, and also to non-EU AIFMs (such US fund managers) that market their funds in the EU via the NPPRs, are set out below:

  • Changes to AIFMD Investor Pre-Contractual Disclosures (for funds in the scope of AIFMD and that will be fundraising on or after 16 April this year): AIFMD 2.0 amends Article 23 of the AIFMD, which is what the AIFMD disclosures in the PPM / AIFMD supplement are based on.  This includes the following additional disclosure item: “a list of fees, charges and expenses that are borne by the AIFM in connection with the operation of the AIF and that are to be directly or indirectly allocated to the AIF”.  AIFMD disclosures should be updated to cover this additional disclosure.  
  • Changes to Annex IV Reporting: AIFMD 2.0 amends certain elements of the Annex IV reporting process, but the new secondary legislation on reporting (which will reshape the reporting templates) is due be published by 16 April 2027. Fund sponsors will be expected to report against the new template following its publication. Ahead of this, fund sponsors should be aware of the additional information requirements arising under AIFMD 2.0 so they are able to comply with them in due course.

If fund sponsors engage a service provider to prepare their Annex IV reports, we recommend discussing any expected changes required to Annex IV reporting processes as part of the general dialogue with these service providers.

  • Additional Data to be Reported to Investors: Fund sponsors should start preparing for certain additional information items to be reported to investors on an annual basis. These additional items include information on all fees, charges and expenses that were directly or indirectly borne by investors as well as the use of subsidiaries and SPVs in relation to the AIF’s investments. These disclosures should be provided at least on an annual basis in the Article 22 AIFMD Annual Reports.

For AIFs managed by EU AIFM the following additional requirements will apply:

  • Delegation and substance: AIFMD 2.0 retains the delegation model but expands the information EU AIFMs must provide to regulators at authorisation stage and on an ongoing basis. This includes more granular reporting on delegation and sub-delegation arrangements and the AIFM’s resources and oversight framework. We recommend reviewing delegation arrangements (including oversight, due diligence and contractual terms) and confirming that the AIFM continues to operate with appropriate substance and control.
  • Loan origination: AIFMD 2.0 introduces a specific regime for loan-originating AIFs and certain loan origination activity, this will apply, for example, to lending activity carried out by a fund.   For funds that carry out such activities, the new AIFMD 2.0 requirements should be assessed and appropriate changes (e.g. to the investment policies and investor disclosures) should be made in order to comply with the new requirements.     
  • Liquidity management tools (relevant only to open-ended AIFs):  for open-ended AIFs managed by EU AIFMs, AIFMD 2.0 introduces a harmonised framework for liquidity management tools. In practice, this will require selecting at least two appropriate tools from the prescribed list, incorporating them in the constitutional documents of the fund, maintaining a written policy , and updating investor disclosure on the tools and their use. There are also notification requirements to the competent authority when certain tools are activated or deactivated. For firms that manage or sponsor open-ended AIFs, the new AIFMD 2.0 requirements should be assessed and appropriate changes made in order to comply with the new requirements.     

Further resources and background on AIFMD 2.0

The below publications and podcasts provide further background to AIFMD 2.0 and its new requirements:

Next Steps

Please do not hesitate to contact the Proskauer UK Regulatory team if you have any questions on AIFMD 2.0 and the next steps to take to comply with the new requirements. 

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Anna Maleva-Otto Anna Maleva-Otto

Anna Maleva-­Otto is a Regulatory partner and a member of the Firm’s Private Capital industry group.

Anna advises on a range of UK financial services regulatory matters, including the impact of EU directives and regulations, the establishment and operation of FCA-­regulated businesses in…

Anna Maleva-­Otto is a Regulatory partner and a member of the Firm’s Private Capital industry group.

Anna advises on a range of UK financial services regulatory matters, including the impact of EU directives and regulations, the establishment and operation of FCA-­regulated businesses in the UK, as well as trading on UK and EU markets.

Anna also often assists clients with the design of their compliance policies and procedures, internal investigations and staff training. She frequently participates in industry working groups in connection with new and emerging regulatory initiatives and has advised asset managers on several key pieces of recent EU legislation, including General Data Protection Regulation (GDPR), Short Selling Regulation, Alternative Investment Fund Managers Directive (AIFMD), the second Markets in Financial Instruments Directive (MiFID II), Market Abuse Regulation (MAR), the Securities Financing Transactions Regulation (SFTR), European Market Infrastructure Regulation (EMIR) and Securitization Regulation.

Anna has been named among the world’s 50 Leading Women in Hedge Funds by The Hedge Fund Journal and frequently speaks and writes on topics related to her areas of experience. She has previously co-authored the UK chapter in the Chambers Alternative Funds Guide – a guide examining key industry trends and regulatory and tax matters impacting funds, managers and investors.

Photo of John Verwey John Verwey

John Verwey is a Regulatory partner and a member of the Firm’s Private Capital industry group.

John advises on financial services regulatory matters at a national UK and European level. He specializes in advising investment firms, including venture, private equity, credit, and hedge…

John Verwey is a Regulatory partner and a member of the Firm’s Private Capital industry group.

John advises on financial services regulatory matters at a national UK and European level. He specializes in advising investment firms, including venture, private equity, credit, and hedge fund managers as well as institutional managers and advisers, on all aspects of the UK and EU regulatory regimes.

Another key area of focus is advising clients in the financial services sector on mergers and acquisitions, re-organisations and associated regulatory approvals.

John represents a variety of clients that range from small start-up fund managers to established global fund advisers and managers. In The Legal 500, John is noted as “an all-rounder who gets into the details and manages client expectations on navigating tricky regulatory requirements”.

Photo of Rachel Lowe Rachel Lowe

Rachel E. Lowe is a special regulatory counsel in the Corporate Department and a member of the Private Investment Funds Group.

Rachel advises on financial services regulation specializing in sustainable finance and ESG regulation. She has particular expertise in drafting and advising on…

Rachel E. Lowe is a special regulatory counsel in the Corporate Department and a member of the Private Investment Funds Group.

Rachel advises on financial services regulation specializing in sustainable finance and ESG regulation. She has particular expertise in drafting and advising on the Sustainable Finance Disclosure Regulation (SFDR) and the Taxonomy Regulation. Rachel has also supported with EU MiFID and AIFMD sustainability updates for clients, including from a governance and organizational perspective, as well as providing drafting and training support. She also advises on the Corporate Sustainability Reporting Directive (CSRD), including analysis of its applicability for large international group structures.

From a UK perspective, Rachel supports clients with the TCFD-related requirements in the Financial Conduct Authority’s ESG Sourcebook and is increasingly engaged on the UK’s Sustainability Disclosure Requirements (SDR).

More broadly, Rachel has worked with litigation colleagues to assist clients with understanding and mitigating greenwashing-related legal and regulatory risk.

Photo of Edward Lister Edward Lister

Edward Lister is a special regulatory counsel and a member of the Private Equity Transactions and Mergers & Acquisitions Groups.

Edward advises a wide range of stakeholders in the insurance industry, including major insurers and reinsurers, insurance intermediaries, Lloyd’s syndicates and insurtech companies.

Edward Lister is a special regulatory counsel and a member of the Private Equity Transactions and Mergers & Acquisitions Groups.

Edward advises a wide range of stakeholders in the insurance industry, including major insurers and reinsurers, insurance intermediaries, Lloyd’s syndicates and insurtech companies. Edward’s practice has a strong focus on commercial and regulatory insurance matters, and Edward regularly advises clients on FCA, PRA and Lloyd’s rules and procedures, including jurisdictional issues, Solvency II / UK regulation, insurance conduct of business standards, systems and controls for insurers and insurance intermediaries, applications for authorisation and the Senior Managers & Certification Regime.

Photo of Sulaiman Malik Sulaiman Malik

Sulaiman Malik is an associate in the Corporate Department and a member of the Private Funds Group.

Sulaiman advises clients on a range of UK and international financial regulation. He advises private equity funds, hedge funds, sovereign wealth funds and other asset managers…

Sulaiman Malik is an associate in the Corporate Department and a member of the Private Funds Group.

Sulaiman advises clients on a range of UK and international financial regulation. He advises private equity funds, hedge funds, sovereign wealth funds and other asset managers, as well as banks, FinTechs, broker-dealers and governments.

Prior to joining Proskauer, Sulaiman trained at Simmons & Simmons in London, where he was seconded to Brevan Howard. He has also spent time at the UK’s Ministry of Justice and as an adviser to the Mayor of Brisbane, in Australia.

Sulaiman is a passionate advocate for diversity and inclusion. He previously worked at Rare, a market-leading diversity consultancy, and provides pro bono legal advice to a range of community and civil rights organizations.

Photo of Michael Singh Michael Singh

Michael is an associate in the Private Funds Group in the Corporate Department.

Michael advises clients on a variety of regulatory issues both from a UK and European perspective. He also helps clients on fund related transactions. His clients include private equity firms…

Michael is an associate in the Private Funds Group in the Corporate Department.

Michael advises clients on a variety of regulatory issues both from a UK and European perspective. He also helps clients on fund related transactions. His clients include private equity firms, investment managers, FinTech companies and wealth management businesses.

He is dual-qualified as a German lawyer (“Rechtsanwalt”) and Solicitor of England and Wales and previously was in-house counsel at Deutsche Bank.